team

our commitment


IAMA is a team of experienced scientists, researchers, and industry experts motivated by a shared commitment to developing new treatments to make an impact on individuals affected by CNS disorders.

leadership


Torsten Madsen
C.E.O.
Laura Cancedda
Founder, Scientific Advisor
Marco De Vivo
Founder, Scientific Advisor
Ciro Spedaliere
Chairman
Federico Bolognani
Clinical Advisor
Annalisa Savardi
Team Leader Neuropharmacology
Marco Borgogno
Team Leader
Discovery Chemistry
Paolo Vigo
Operations Manager

our values

Working at IAMA Therapeutics


The IAMA team is committed to excellence, innovation, integrity, equality, respect for diversity, and the sustainability of future generations.

Excellence: being outstanding or truly the best at something. We aim for excellence in everything we do.
 
Innovation: introducing new ideas, devices, or methods. We aim to create a new normality by disrupting the status quo.
 
Integrity: being honest and showing a consistent and uncompromising adherence to strong moral and ethical principles and values. We are true to ourselves and would do nothing that demeans or dishonors us.

Community development: promoting, sustaining, supporting and maintaining community action. We positively impact the brain disease community as we seek to include individuals and families in every aspect of what we do.
 
Sustainability: meeting the needs of the present without compromising the ability of future generations to meet their needs. We understand the environmental impacts of our business and provide clear targets and solutions to the increasing demand.

At IAMA Therapeutics, we offer equal employment opportunities to all qualified employees and candidates. In line with our values, we ensure equal opportunities in the selection and contractual treatment regardless of race, religion, color, sex, gender identity, sexual orientation, age, physical or mental disability, national origin, veteran status, or any other characteristic protected by applicable law.